Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome: Part II. Diagnosis and management
- PMID: 37714216
- DOI: 10.1016/j.jaad.2023.08.084
Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome: Part II. Diagnosis and management
Abstract
In the second part of this Continuing Medical Education article on paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome (PNP/PAMS), its diagnostic criteria, investigative work-up, and management are reviewed. PNP/PAMS is a rare autoimmune blistering disorder associated with high morbidity and mortality. Recognizing PNP/PAMS's key features and its diagnostic criteria is critical in initiating appropriate work-up. Evaluating PNP/PAMS requires knowledge of its findings on histopathology, direct immunofluorescence, indirect immunofluorescence, and enzyme-linked immunosorbent assay. Lastly, treatments for PNP/PAMS are reviewed with suggestions based on case reports and expert opinions in the literature.
Keywords: ELISA; PAMS; criteria; diagnosis; histopathology; paraneoplastic; paraneoplastic autoimmune syndrome; pemphigus; therapy; treatment.
Copyright © 2023 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest None disclosed.
Similar articles
-
Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome: Part I. Clinical overview and pathophysiology.J Am Acad Dermatol. 2024 Jul;91(1):1-10. doi: 10.1016/j.jaad.2023.08.020. Epub 2023 Aug 17. J Am Acad Dermatol. 2024. PMID: 37597771 Review.
-
A systematic review of paraneoplastic pemphigus and paraneoplastic autoimmune multiorgan syndrome: Clinical features and prognostic factors.J Am Acad Dermatol. 2025 Feb;92(2):307-310. doi: 10.1016/j.jaad.2024.10.013. Epub 2024 Oct 18. J Am Acad Dermatol. 2025. PMID: 39426525
-
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV).J Eur Acad Dermatol Venereol. 2023 Jun;37(6):1118-1134. doi: 10.1111/jdv.18931. Epub 2023 Mar 25. J Eur Acad Dermatol Venereol. 2023. PMID: 36965110 Free PMC article.
-
Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).Dermatol Clin. 2011 Oct;29(4):607-12. doi: 10.1016/j.det.2011.06.016. Epub 2011 Aug 15. Dermatol Clin. 2011. PMID: 21925005 Review.
-
Paraneoplastic autoimmune multiorgan syndrome: review of the literature and support for a cytotoxic role in pathogenesis.Autoimmunity. 2006 Nov;39(7):617-30. doi: 10.1080/08916930600972099. Autoimmunity. 2006. PMID: 17101506 Review.
Cited by
-
Paraneoplastic Pemphigus in a Patient With Pheochromocytoma: A Report of a Rare Case.Cureus. 2025 Feb 22;17(2):e79459. doi: 10.7759/cureus.79459. eCollection 2025 Feb. Cureus. 2025. PMID: 40135007 Free PMC article.
-
Mechanisms of autoimmune-mediated paraneoplastic syndromes: immune tolerance and disease pathogenesis.Front Immunol. 2025 May 9;16:1608934. doi: 10.3389/fimmu.2025.1608934. eCollection 2025. Front Immunol. 2025. PMID: 40416967 Free PMC article. Review.
-
[Autoimmune blistering dermatosis as a paraneoplastic syndrome secondary to testicular cancer].Rev Med Inst Mex Seguro Soc. 2024 Jul 1;62(4):1-6. doi: 10.5281/zenodo.11397245. Rev Med Inst Mex Seguro Soc. 2024. PMID: 39546554 Free PMC article. Spanish.
-
Paraneoplastic Dermatoses: A Clue for Underlying Malignancies.J Clin Med. 2025 Feb 5;14(3):1014. doi: 10.3390/jcm14031014. J Clin Med. 2025. PMID: 39941684 Free PMC article. Review.
-
Complete Resolution of Atypical Paraneoplastic Pemphigus Following Treatment With Dupilumab.Cureus. 2025 Mar 23;17(3):e81033. doi: 10.7759/cureus.81033. eCollection 2025 Mar. Cureus. 2025. PMID: 40264631 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous